ImmunoPrecise Antibodies Ltd. (CVE:IPA – Get Free Report)’s share price shot up 0.8% during mid-day trading on Friday . The company traded as high as C$6.70 and last traded at C$6.50. 19,980 shares changed hands during mid-day trading, an increase of 3% from the average session volume of 19,376 shares. The stock had previously closed at C$6.45.
ImmunoPrecise Antibodies Price Performance
The stock has a fifty day moving average of C$6.50 and a 200-day moving average of C$6.50. The company has a quick ratio of 4.29, a current ratio of 5.06 and a debt-to-equity ratio of 1.70. The firm has a market capitalization of C$162.08 million and a P/E ratio of -7.30.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes.
Read More
- Five stocks we like better than ImmunoPrecise Antibodies
- Most active stocks: Dollar volume vs share volume
- Texas Roadhouse Stock Steering for New Highs This Year
- How to Invest in the Best Canadian Stocks
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
